Regulation of Fc epsilon receptor 2 (CD23) expression on a human eosinophilic cell line EoL3 and a human monocytic cell line U937 by transforming growth factor beta

Cell Immunol. 1989 Aug;122(1):96-107. doi: 10.1016/0008-8749(89)90151-2.

Abstract

Regulation of low-affinity receptors for IgE (Fc epsilon R2/CD23) on a human eosinophilic cell line EoL3 and a human monocytic cell line U937 was studied using an anti-Fc,R2/CD23 monoclonal antibody H107 by flow cytometry. While platelet-activating factor, interleukin 4, and interferon gamma significantly augmented Fc epsilon R2/CD23 expression on both cell lines, transforming growth factor beta (TGF beta) inhibited both the basal level of Fc epsilon R2/CD23 expression and the enhanced Fc epsilon R2/CD23 expression induced by these reagents in dose- and time-dependent manners. However, TGF beta did not significantly suppress the high basal level of Fc epsilon R2/CD23 expression on RPMI 8866 cells. These results suggest that Fc epsilon R2/CD23 expression on EoL3 and U937 cells is regulated by various cytokines and growth factors, and that TGF beta plays an important regulatory role in IgE-mediated immune responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Differentiation, B-Lymphocyte / analysis*
  • Cell Line, Transformed
  • Dexamethasone / pharmacology
  • Eosinophils / immunology*
  • Humans
  • Interferon-gamma / pharmacology
  • Interleukin-4
  • Interleukins / pharmacology
  • Leukemia, Eosinophilic, Acute / immunology
  • Leukemia, Myeloid / immunology
  • Monocytes / immunology*
  • Platelet Activating Factor / pharmacology
  • Receptors, Fc / analysis*
  • Receptors, IgE
  • Transforming Growth Factors / pharmacology*

Substances

  • Antigens, Differentiation, B-Lymphocyte
  • Interleukins
  • Platelet Activating Factor
  • Receptors, Fc
  • Receptors, IgE
  • Interleukin-4
  • Transforming Growth Factors
  • Dexamethasone
  • Interferon-gamma